Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

42 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-05-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Technical Development of Cardiovascular Magnetic Resonance Imaging

NCT04927429

Cardiovascular Disease

RECRUITING

Magnetocardiography (MCG) in Subjects Undergoing CT Angiography (CTA)

NCT00574561

Chest Pain

WITHDRAWN

Assessment Of MRI In Patients With Implanted Cardiac Devices

NCT02815384

Arrhythmias, Cardiac

WITHDRAWN

Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures

NCT00692991

Myocardial Infarction Angina, Unstable Cardiomyopathy, Hypertrophic

COMPLETED

MRI and Computational Simulation Cardiology Study

NCT03149341

Congenital Heart Disease Pulmonary Hypertension

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abnormalities, Cardiovascular

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* Ability to give informed, written consent
* Not Pregnant or breastfeeding

Exclusion Criteria

* Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers)
* Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis
* History of uncontrolled claustrophobia

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes